Personality and CML medication adherence study
Part of Blood & lymphatic, Cancer clinical trials.
This study looks at how a person's personality might affect how well they take their CML medication. It's for people with chronic phase CML who are taking certain targeted therapy pills (imatinib, dasatinib, bosutinib, or nilotinib).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have chronic myeloid leukemia (CML) that is in the chronic phase (the earliest stage)
- You are currently taking one of these four CML medications: imatinib, dasatinib, bosutinib, or nilotinib
- You are either a patient at the UCI Chao Family Comprehensive Cancer Center, or a member of a CML Buster Foundation support group
- You can read and speak English
- You are able to understand the study and make a decision to participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how certain CML treatments called tyrosine kinase inhibitors affect blood sugar and cholesterol levels in people with chronic myeloid leukemia. It may help understand if these drugs change metabolism.
This study looks at how your current leukemia medicines and herbal or plant-based products may interact, and how that could affect outcomes in chronic myeloid leukemia. It may help doctors better understand which drug combinations are safest and most effective.
This study tracks the experiences and health outcomes of people with chronic myeloid leukemia (CML) who are taking approved first or second line tyrosine kinase inhibitor (TKI) medicines. It helps doctors learn how these treatments work in everyday care.
This study looks at how your 'biological age' (how old your body seems) affects how well you do on targeted therapy for chronic myeloid leukemia. It aims to personalize your care by combining age and frailty information.
This trial tests whether having a specially trained nurse manage your care can improve outcomes for people with chronic myeloid leukemia (CML) who take oral medication. It may be a good fit if you are starting or changing oral therapy.
This trial is a real-life study that collects information from people living with chronic myeloid leukemia (CML). It may help doctors understand how CML treatments are used in practice and how well they work over time.
Hear when a new Chronic Myeloid Leukemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.